FDA orders stronger fungal warnings
Thursday, September 4, 2008 - 11:35
in Health & Medicine
WASHINGTON, Sept. 4 (UPI) -- The U.S. Food and Drug Administration says manufacturers of Humira, Cimzia, Enbrel and Remicade must emphasize the risk of developing fungal infections.
Read the whole article
See latest science articles from UPI
Latest Science Newsletter
Get the latest and most popular science news articles of the week in your Inbox!Related
- Predicting the risk of a common fungal infection after stem cell transplantationFri, 20 Jun 2008, 2:56:58 EDT
- Voriconazole: A highly potent treatment for fungal infectionsTue, 16 Dec 2008, 9:36:41 EST
- Using electrons to treat organic seedsFri, 10 Oct 2008, 11:56:51 EDT
- Herpes drug inhibits HIV in patients infected with both virusesMon, 15 Sep 2008, 16:50:11 EDT
- Fungal pill could provide asthma relief for 150,000 UK sufferersMon, 29 Dec 2008, 10:23:59 EST